The day after the day HIV/AIDS is in the news. A collection of short messages sent as part of a big Tweetup to find a “Big Idea to end AIDS”. The following messages have been organised in broad categories that often overlap. About the “Big
Morenike Ukpong I am in Ethiopia and I sat down through a 2 days session listening to data presentation about the HIV context and situation in Africa. As usual, I was all out to hear and listen about what the data was saying about
2011, the year of PrEP. In less than 18 months 6 clinical trials investigating the potential use of HIV antiretrovirals (ARV) for the prevention of HIV acquisition have rocked the HIV prevention world. First it was the South African CAPRISA announcing in July 2010
Closure of oral Tenofovir arm in VOICE Pre-Exposure Prophylaxis trial: PrEP as a “niche intervention”?
The Microbicides Trial Network (MTN) announced yesterday that its VOICE (Vaginal and Oral Interventions to Control the Epidemic, MTN003) HIV Pre-Exposure Prophylaxis (PrEP) prevention study will discontinue the daily oral tenofovir arm of the trial. The decision follows an interim review of the trial’s data
(Updated April 19, 18:00) In July 2010 the world of HIV prevention felt the first tremor of hope that the fight against the virus that causes AIDS was at a turning point in its history after the pivotal CAPRISA trial (a “game changer”) showed